Trending Now
Moleculin Biotech Inc. (NASDAQ:MBRX) Submits Expansion Request For Annamycin Study Sites...
Moleculin Biotech Inc. (NASDAQ:MBRX) has announced the submission of requests to regulatory authorities in Poland for approval for the opening of two more sites...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
All Eyes on Oil Stocks as Shortage Fears Grow (MTDR, AGYP,...
The oil market is likely going to become a big deal in 2021 because 2020 featured such brutal action, at one point...
MAKE IT MODERN
LATEST REVIEWS
Sarepta Therapeutics (NASDAQ:SRPT) Announces SRP-9001 Study Results Showing Sustained Functional Improvement...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) has announced its two-year study follow up results from four Duchene muscular dystrophy clinical study subjects that received SRP-9001.
SRP-9001 showing...
MAKE IT MODERN
PERFORMANCE TRAINING
Myovant Sciences (NYSE:MYOV) Launches A Grant Program, “Forward for Health Equity” Aimed At Improving...
Myovant Sciences (NYSE:MYOV) has launched its “Forward for Health Equity” grant program to improve healthcare access in uterine fibroids and prostate cancer.
Myovant to issue...
Ascendis Pharma A/S (NASDAQ: ASND) Receives FDA Approval For SKYTROFA In Paediatric GHD...
Ascendis Pharma A/S (NASDAQ: ASND) has approval for SKYTROFA (lonapegsomatropinc-tcgd) in pediatric patient treatment for those above one year and weighing 11.5 Kg that...
Moderna Inc. (NASDAQ:MRNA) Partners with Catalent Inc. (NYSE:CTLT) To Ramp Up COVID-19 Vaccine Manufacture
Moderna Inc. (NASDAQ:MRNA) has announced a partnership with contract drugmaker Catalent Inc. (NYSE:CTLT) to prepare around 100 million initial doses of its COVID-19 vaccine...
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Receives Approval To Commence Studies On Oravax’s Oral COVID-19...
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) has announced Oravax Medical Inc., its majority-owned subsidiary, has received approval from the South African Health Products Regulatory Authority...
Technology, Legislation, the Supreme Court, and Your Cannabis Portfolio (YCBD, ECOX, TLRY, GRWG)
There are two dimensions to the cannabis investment theme: the commodity market’s boom and bust cycle, and the legislative “arrow” of time.
MAKE IT MODERN
